List of works - Roy Fleischmann

4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

scientific article published on 14 March 2018

A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

scientific article published on 07 June 2019

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis

scientific article published on 15 August 2018

Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis

scientific article published on 26 June 2020

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example

scientific article

Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials

scientific article published on 10 November 2019

Distinguishing rheumatoid arthritis from psoriatic arthritis

scientific article published on 13 August 2018

Dr. Fleischmann replies

scientific article published on 15 July 2019

EULAR PsA management recommendations 2019: can the recommendations be improved?

scientific article published on 01 June 2020

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

scientific article published on 11 August 2020

Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study

scientific article published on 01 March 2020

Looking Back on 2019 in Rheumatology and What to Expect from 2020

scientific article published on 10 December 2019

Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?

scientific article published on 16 January 2020

Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

scientific article published on 01 October 2019

Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study.

scientific article published on 9 April 2018

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

scientific article published on 06 November 2020

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research

scientific article published on 01 November 2020

Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis

scientific article published on 04 November 2020

The American College of Rheumatology White Paper on Biosimilars: It Isn't All White-There Is Some Gray and Black.

scientific article published on 7 February 2018

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study

scientific article published on 24 April 2019

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial

scientific article published on 28 August 2019

Value of the Multibiomarker Disease Activity Score to Predict Remission in RA: What Does the Evidence Show?

scientific article published on 01 May 2019

List of works by Roy Fleischmann